Skip to main content
. 2023 Oct 4;5(6):775–787. doi: 10.1016/j.jaccao.2023.08.007

Figure 3.

Figure 3

Cardiac Event Cumulative Incidence Curves Adjusted for Noncardiac Death

(A) Cumulative incidence of adverse cardiac events with median time to the first cardiac event following radiotherapy of 21.5 months. The 5-year cardiac event incidence was 13.8% (95% CI: 10.6%-17.0%). (B) Cardiac event incidence for left coronary arteries (TotalLeft) receiving high (V15 >2.53 cc) vs low (V15 ≤2.53 cc) radiotherapy dose, with a 5-year incidence of 26.7% vs 10.6%, respectively. (C) Adverse cardiac event incidence in high (score >5) vs low (score ≤5) CAC score to TotalLeft, with a 5-year cardiac event incidence of 28.4% vs 10.7%, respectively. (D) Cumulative risk estimates when stratifying by linear function of fixed covariate values obtained with our competing-risk regression model including age, TotalLeft CAC score >5, and TotalLeft V15. The 5-year incidence of adverse cardiac events was 6.9% for the low-risk group and 28.9% for the high-risk group. Abbreviations as in Figure 2.